A--Clinical Studies for Antiviral Therapies

A programmatic priority of the Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases is the conduct of clinical trials of therapies for severe, acute and chronic, non-HIV, viral diseases that are important public health problems. The focus of these studies continues to be on herpesvirus infections, as well as other rare or emerging viral diseases in special clinical populations such as the immunosuppressed, elderly, or children that are not a high priority for the pharmaceutical industry. It is anticipated that one (1) cost-reimbursement, completion type contract will be awarded for a period of seven (7) years, beginning approximately 7/1/2003. RFP-NIH-NIAID-DMID-03-08 will be available electronically on or about September 4, 2002 and may be accessed through the NIAID Contract Management Branch (CMB) Home Page by using the following electronic address and instructions: NIAID/CMB Home Page (via the WWW): Use http://www.niaid.nih.gov/contract to access the NIAID/CMB Home Page. Once at the NIAID/CMB Home Page, click on the "RFPs" link and then click on "RFP NIH-NIAID-DMID-03-08." Please note that the RFP has been revised to include only the Work Statement, Deliverable and Reporting Requirements, Special Requirements, Technical Evaluation Criteria, and the Specific RFP Instructions and Provisions. All information required for the submission of an offer will be contained in the electronic RFP package. Responses to this RFP will be due on 11/15/02. Any responsible offeror may submit a proposal for consideration by the Government. This advertisement does not commit the Government to award a contract.